v3.26.3
Supplemental Equity, Redeemable Noncontrolling Interest, and Comprehensive Income Information - Schedule of Consolidated Statement of Changes in Equity (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Increase (decrease) in equity        
Balance at the beginning of the period $ 3,005 $ 4,351 $ 4,747 $ 3,894
Net income (loss) including noncontrolling interests 1,418 841 3,015 2,688
Adjustment to redeemable noncontrolling interest (41)   (41)  
Other comprehensive income (loss), net of tax 70 89 83 594
Solventum spin-off       (3)
Dividends declared (403) (389) (1,216) (1,175)
Purchase of noncontrolling interest       1
Stock-based compensation 44 52 144 168
Reacquired stock (229) (473) (3,232) (2,694)
Issuances pursuant to stock option and benefit plans 338 221 702 1,219
Dividend to noncontrolling interest (15) (17) (15) (17)
Investment by noncontrolling interest (18)   (18)  
Balance at the end of the period 4,169 4,675 4,169 4,675
Increase (decrease) in redeemable noncontrolling interest        
Balance at the beginning of the period 0   0  
Net loss (8)   (8)  
Adjustment to redeemable noncontrolling interest 41   41  
Other comprehensive income (loss), net of tax (6)   (6)  
Investment by noncontrolling interest 944   944  
Balance at the end of the period 971   971  
Common stock and additional paid-in capital        
Increase (decrease) in equity        
Balance at the beginning of the period 7,549 7,354 7,449 7,238
Stock-based compensation 44 52 144 168
Investment by noncontrolling interest (18)   (18)  
Balance at the end of the period 7,575 7,406 7,575 7,406
Retained earnings        
Increase (decrease) in equity        
Balance at the beginning of the period 38,633 37,693 38,258 36,797
Net income (loss) including noncontrolling interests 1,414 834 3,000 2,673
Adjustment to redeemable noncontrolling interest (41)   (41)  
Solventum spin-off       (14)
Dividends declared (403) (389) (1,216) (1,175)
Issuances pursuant to stock option and benefit plans (16) (35) (414) (178)
Balance at the end of the period 39,587 38,103 39,587 38,103
Treasury stock        
Increase (decrease) in equity        
Balance at the beginning of the period (38,177) (35,542) (35,936) (34,462)
Reacquired stock (229) (473) (3,232) (2,694)
Issuances pursuant to stock option and benefit plans 354 256 1,116 1,397
Balance at the end of the period (38,052) (35,759) (38,052) (35,759)
Accumulated other comprehensive income (loss)        
Increase (decrease) in equity        
Balance at the beginning of the period (5,053) (5,215) (5,069) (5,731)
Other comprehensive income (loss), net of tax 70 93 86 598
Solventum spin-off       11
Balance at the end of the period (4,983) (5,122) (4,983) (5,122)
Nonredeemable noncontrolling interest        
Increase (decrease) in equity        
Balance at the beginning of the period 53 61 45 52
Net income (loss) including noncontrolling interests 4 7 15 15
Other comprehensive income (loss), net of tax   (4) (3) (4)
Purchase of noncontrolling interest       1
Dividend to noncontrolling interest (15) (17) (15) (17)
Balance at the end of the period $ 42 $ 47 $ 42 $ 47